Sublingual-swallow immunotherapy (SLIT) with a standardized five-grass- pollen extract (drops and sublingual tablets) versus placebo in seasonal rhinitis

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 54, Issue 8, 1999, Pages 819-828

  Pradalier, A ^a   Basset, D ^c   Claudel, A ^c   Couturier, P ^c   Wessel, F ^c   Galvain, S ^b   André, Claude ^b  

^a Hopital Universitaire Louis   (France)

^b Stallergenes SA   (France)

^c NONE

Author keywords

Asthma; Five grass pollen extract; Rhinoconjunctivitis; Sublingual immunotherapy

Indexed keywords

PLACEBO;

ADOLESCENT; ADULT; ALLERGIC RHINITIS; ARTICLE; ASTHMA; CHILD; CLINICAL TRIAL; CONJUNCTIVITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSAGE FORM; DRUG SAFETY; FEMALE; GRASS POLLEN; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBLINGUAL DRUG ADMINISTRATION; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ADULT; ALLERGENS; CHILD; DESENSITIZATION, IMMUNOLOGIC; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INTRADERMAL TESTS; MALE; PLANT EXTRACTS; POACEAE; POLLEN; RHINITIS, ALLERGIC, SEASONAL;

EID: 0032779394     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.1999.00077.x     Document Type: Article

References (18)

1. 1. Malling H-J. Sublingual immunotherapy. Clin Exp Allergy 1996;26:1228-1231.
2. 2. Scadding GK, Brostoff J. Low dose sublingual therapy in patients with allergic rhinitis due to house dust mite. Clin Allergy 1986;16:483-491
3. 3. van Niekerk CH, De Wet JI. Efficacy of grassmaize pollen oral immunotherapy in patients with seasonal hay-fever: a double-blind study. Clin Allergy 1987;17:507-513.
4. 4. Casanovas M, Guerra F, Moreno C, Miguel R, Maranon F, Daza JC. Double-blind, placebo-controlled clinical trial of preseasonal treatment with allcrgenic extracts of Olea earopaea pollen administered sublingually. J Investig Allergol Clin Immunol 1994;4:305-314.
5. 5. Clavel R, Bousquet J, André C. Clinical efficacy of sublingual-swallow immunotherapy: a double-blind, placebo-controlled trial of a standardized five grass pollen extract in rhinitis. Allergy 1998;53:493-498.
6. 6. Feliziani V, Lattuada G, Partmiani S, Dall' Aglio PP. Safety and efficacy of sublingual rush immunotherapy with grass allergen extracts. A double-blind study. Allergol Immunopathol (Madr) 1995;23:224-230.
7. 7. Passalacqua G, Albano M, Fregonese L, et al. Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis. Lancet 1998;351:629-632.
8. 8. Sabbah A, Hassoun S, Le Sellin J, André C, Sicard H. A double-blind, placebo-controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract. Allergy 1994;49:309-313.
9. 9. Tari MG, Mancino M, Monti G. Efficacy of sublingual immunothcrapy in patients with rhinitis and asthma due to house dust mites. A double-blind study. Allergol Immunopathol (Madr) 1990;8:277-284.
10. 10. Troise C, Voltolini S, Canessa A, Pecora S, Negrini AC. Sublingual immunotherapy in Parietaria pollen induced rhinitis: a double-blind study. J Investig Allergol Clin Immunol 1995;5:25-30.
11. 11. Vourdas D, Syrigou E, Potamianou P, et al. Double-blind placebo-controlled evaluation of sublingual immunotherapy with standardized olive tree pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive tree pollen sensitization. Allergy 1998;53:662-672.
12. 12. Nelson HS, Oppenheimer J, Vatsia GA, Buchmeier A. A double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized cat extract. J Allergy Clin Immunol 1993;92:229-236.
13. 13. Bousquet J, Hejjaoui A, Dhivert H, Clauzel AM, Michel FB. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. III. Systemic reactions during the rush protocol in patients suffering from asthma. J Allergy Clin Immunol 1989;83:797-802.
14. 14. Bousquet J, Hejjaoui A, Dhivert H, Clauzel AM, Michel FB. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. II. Prediction of efficacy of immunotherapy. J Allergy Clin Immunol 1988;82:971-977.
15. 15. Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials. CONSORT Statement. JAMA 1996;276:637-639.
16. 16. van Wilsen EJG, van Hongstraten IMW, Brevé J, et al. Dendritic cells of the oral mucosa and the induction of oral tolerance. A local affair. Immunology 1994;83:128-132.
17. 17. Jutel M, Pichler WJ, Skrbic D, Urwyler A, Dahinden C, Müller UR. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen-stimulated T cell cultures. J Immunol 1995;154:187-194.
18. 18. McHugh SM, Deighton J, Stewart AG, Laehmann PJ, Ewan PW. Bee venom immunotherapy induces a shift in cytokine responses from a TH-2 to a TH-1 dominant pattern: comparison of rush and conventional immunotherapy. Clin Exp Allergy 1995;25:828-838.